Evidence map›Paper›PMID 12525653›Full record

ArticleJournal of virology2003

Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.

Daniel N Streblow, Craig Kreklywich, Qiang Yin, V T De La Melena, Christopher L Corless, Patricia A Smith, Christina Brakebill, Judith W Cook, Cornelis Vink, Cathrien A Bruggeman and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection.Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Article
  3. Blocking the IL-1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV-accelerated chronic rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  4. Control of Cytokines in Latent Cytomegalovirus Infection.Pathogens (Basel, Switzerland) · 2020
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2015
    Article
  10. Article
  11. Article
  12. Endothelial dysfunction and cardiac allograft vasculopathy.Journal of cardiovascular translational research · 2013
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Daniel N StreblowDepartments of Molecular Microbiology, Oregon Health Sciences University, Portland, Oregon 97201, USA.
Craig Kreklywich
Qiang Yin
V T De La Melena
Christopher L Corless
Patricia A Smith
Christina Brakebill
Judith W Cook
Cornelis Vink
Cathrien A Bruggeman
Jay A Nelson
Susan L Orloff
Oregon Health & Science University · USMaastricht University · NLGene Therapy Laboratory · FR

Funding

MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCYR01AI021640 · NIAID · UNIVERSITY OF GUELPH · PI Meaghan H Hancock · 1985 to 2026
$8.1M
Molecular Aspects of Cytomegalovirus LatencyR37AI021640 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HANCOCK, MEAGHAN H · 2018 to 2024
$4.0M
CHEMOKINE RECEPTORS IN VASCULAR DISEASER01HL065754 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NELSON, JAY A · 2000 to 2007
$2.7M
VIRAL CHEMOKINE RECEPTORS: TRANSPLANT VASCULAR SCLEROSISR01HL066238 · NHLBI · OREGON HEALTH AND SCIENCE UNIVERSITY · PI ORLOFF, SUSAN L · 2001 to 2003
$793k
NHLBI NIH HHS HL 65754NHLBI NIH HHS HL 66238-01NHLBI NIH HHS R01 HL065754NHLBI NIH HHS R01 HL066238NIAID NIH HHS AI 21640NIAID NIH HHS R01 AI021640
6 · The paper itself

Abstract

Cytomegalovirus (CMV) infections have been shown to dramatically affect solid organ transplant graft survival in both human and animal models. Recently, it was demonstrated that rat CMV (RCMV) infection accelerates the development of transplant vascular sclerosis (TVS) in both rat heart and small bowel graft transplants. However, the mechanisms involved in this process are still unclear. In the present study, we determined the kinetics of RCMV-accelerated TVS in a rat heart transplant model. Acute RCMV infection enhances the development of TVS in rat heart allografts, and this process is initiated between 21 and 24 days posttransplantation. The virus is consistently detected in the heart grafts from day 7 until day 35 posttransplantation but is rarely found at the time of graft rejection (day 45 posttransplantation). Grafts from RCMV-infected recipients had upregulation of chemokine expression compared to uninfected controls, and the timing of this increased expression paralleled that of RCMV-accelerated neointimal formation. In addition, graft vessels from RCMV-infected grafts demonstrate the increased infiltration of T cells and macrophages during periods of highest chemokine expression. These results suggest that CMV-induced acceleration of TVS involves the increased graft vascular infiltration of inflammatory cells through enhanced chemokine expression.

Indexed as

AnimalsChemokine CX3CL1Chemokine CXCL10ChemokinesChemokines, CChemokines, CX3CChemokines, CXCChronic DiseaseCytomegalovirusGraft RejectionHeart TransplantationInterferon-gammaLymphokinesMaleMembrane ProteinsRatsChemokine CX3CL1Chemokine CXCL10ChemokinesChemokines, CChemokines, CX3CChemokines, CXCCX3CL1 protein, humanCx3cl1 protein, ratInterferon-gammaLymphokineslymphotactinMembrane ProteinsSialoglycoproteinsXCL1 protein, human

Identifiers

PMID12525653
PMCPMC140920
OpenAlexW2049497606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.